HK60184A - 4-hydroxyphenylalkanolamine derivatives and preparation thereof - Google Patents

4-hydroxyphenylalkanolamine derivatives and preparation thereof

Info

Publication number
HK60184A
HK60184A HK601/84A HK60184A HK60184A HK 60184 A HK60184 A HK 60184A HK 601/84 A HK601/84 A HK 601/84A HK 60184 A HK60184 A HK 60184A HK 60184 A HK60184 A HK 60184A
Authority
HK
Hong Kong
Prior art keywords
hydroxyphenylalkanolamine
derivatives
preparation
hydroxyphenylalkanolamine derivatives
Prior art date
Application number
HK601/84A
Other languages
English (en)
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of HK60184A publication Critical patent/HK60184A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK601/84A 1976-06-25 1984-08-02 4-hydroxyphenylalkanolamine derivatives and preparation thereof HK60184A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69985676A 1976-06-25 1976-06-25
US80337277A 1977-06-03 1977-06-03

Publications (1)

Publication Number Publication Date
HK60184A true HK60184A (en) 1984-08-10

Family

ID=27106508

Family Applications (1)

Application Number Title Priority Date Filing Date
HK601/84A HK60184A (en) 1976-06-25 1984-08-02 4-hydroxyphenylalkanolamine derivatives and preparation thereof

Country Status (21)

Country Link
JP (1) JPS5321134A (enExample)
AR (2) AR220896A1 (enExample)
AT (1) AT354420B (enExample)
AU (1) AU512626B2 (enExample)
CA (1) CA1091245A (enExample)
CH (2) CH627447A5 (enExample)
DE (1) DE2728641A1 (enExample)
DK (1) DK146386C (enExample)
ES (1) ES460040A1 (enExample)
FI (1) FI771976A7 (enExample)
FR (1) FR2366272A1 (enExample)
GB (1) GB1544872A (enExample)
HK (1) HK60184A (enExample)
IE (1) IE45631B1 (enExample)
IL (1) IL52353A (enExample)
LU (1) LU77604A1 (enExample)
NL (1) NL7707128A (enExample)
NO (1) NO144848C (enExample)
PH (2) PH15041A (enExample)
PT (1) PT66713B (enExample)
SE (1) SE7707341L (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410548A (en) 1980-07-09 1983-10-18 Reckitt & Colman Products Limited Propanolamine derivatives
DE3128117A1 (de) * 1980-07-29 1982-03-11 Yamanouchi Pharmaceutical Co., Ltd., Tokyo Neue phenyl-aethylaminderivate, verfahren zu ihrer herstellung
FR2623804B1 (fr) * 1987-11-27 1990-03-23 Elf Aquitaine Acylation des phenols
AU620573B2 (en) * 1987-11-27 1992-02-20 Societe Nationale Elf Aquitaine Process for phenol alkylthiolation and its application to the synthesis of 4-acyl-2-alkylthiophenols
US5101065A (en) * 1991-02-04 1992-03-31 Imperial Chemical Industries Plc Acetophenone intermediates
DE69231100T2 (de) 1991-08-21 2001-02-15 Smith & Nephew, Inc. Flüssigkeitsbehandlungssystem
CA2319131A1 (en) 1998-01-26 1999-07-29 Walter H. Moos Mitochondria protecting agents for treating mitochondria associated diseases
DE60008697T2 (de) * 2000-03-28 2005-02-10 Council Of Scientific And Industrial Research Verfahren zur Herstellung von 4-(P-methoxyphenyl)-2-amino-butane und Insektizide
EA200500234A1 (ru) 2002-08-19 2005-08-25 Пфайзер Продактс Инк. Комбинированная терапия гиперпролиферативных болезней
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
JP5719292B2 (ja) * 2009-05-19 2015-05-13 本州化学工業株式会社 トリスフェノール類及びそのモノエステル置換体の製造方法及び4−アシルアラルキルフェノール誘導体
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104324977A (zh) * 2014-10-22 2015-02-04 无锡市得力手机械有限公司 一种倒立式拉丝机的卸线车
HU231124B1 (hu) * 2016-02-10 2020-12-28 Egis Gyógyszergyár Zrt. Eljárás morfológiailag egységes mirabegron és mirabegron monohidroklorid előállítására
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
NO144848B (no) 1981-08-17
DE2728641A1 (de) 1978-01-05
PT66713A (en) 1977-07-01
NO144848C (no) 1981-11-25
SE7707341L (sv) 1978-02-13
AU512626B2 (en) 1980-10-23
AR227126A1 (es) 1982-09-30
AU2636877A (en) 1979-01-04
AR220896A1 (es) 1980-12-15
LU77604A1 (enExample) 1978-02-01
CA1091245A (en) 1980-12-09
GB1544872A (en) 1979-04-25
CH627447A5 (en) 1982-01-15
IL52353A0 (en) 1977-08-31
FI771976A7 (enExample) 1977-12-26
FR2366272A1 (fr) 1978-04-28
FR2366272B1 (enExample) 1981-03-06
NL7707128A (nl) 1977-12-28
JPS5321134A (en) 1978-02-27
DK281777A (da) 1977-12-26
CH630068A5 (en) 1982-05-28
ATA449377A (de) 1979-06-15
DK146386B (da) 1983-09-26
ES460040A1 (es) 1978-05-01
PH15041A (en) 1982-05-20
IE45631L (en) 1977-12-25
NO772245L (no) 1977-12-28
PH14332A (en) 1981-05-29
IE45631B1 (en) 1982-10-20
AT354420B (de) 1979-01-10
DK146386C (da) 1984-03-12
IL52353A (en) 1981-07-31
PT66713B (en) 1978-11-21

Similar Documents

Publication Publication Date Title
JPS52105162A (en) Phthleic derivatives and preparation thereof
JPS52105131A (en) Substituted phenylamidines and preparation thereof
IL59567A0 (en) Oxiranylmethyltetrahydropyran derivative and its preparation
IL53504A (en) Polyfluoroallyloxy compounds and their preparation
IL60155A0 (en) Substituted phenoxybenzylalcohols and their preparation
JPS5379844A (en) Cyclopentanee11amine and like * and its preparation
AU512626B2 (en) 4-Hydroxyphenylalkanolamine derivatives and preparation thereof
JPS5379841A (en) Aminoosugar derivative * its preparation and use
JPS52111552A (en) 44androstenee33one and preparation thereof
JPS5289669A (en) Thiazolidine derivatives and preparation thereof
JPS5312861A (en) Benzimdazole derivative and its preparation
JPS52148061A (en) 66carboxymethyl thiocortisol and derivatives thereof
JPS5325565A (en) Novel aryltrifluoroethylamine and its preparation
GB1519747A (en) 2 - arylpiperazine derivatives and the preparation thereo
ZA776647B (en) New piperidinopropyl derivatives and the preparation thereof
JPS52131534A (en) Aralkylarylamine and preparation thereof
JPS5291859A (en) 22furanones and preparation thereof
IL52668A (en) 7 -amino-1-oxa-1-dethiacephalosporins and their preparation
JPS5315368A (en) Novel 22phenyllindole derivative and preparation thereof
JPS5346977A (en) 55secondary alkylidenehydantoin and its preparation
JPS52100480A (en) Substituted ppaminophenyllasstriazinedione and its preparation
JPS52116462A (en) 22oxoopyrrolidine derivative and preparation thereof
JPS5297953A (en) Tetrahydronaphthaline triol derivatives and preparation thereof
JPS5291863A (en) Novel 22nitroimidazole derivatives and preparation thereof
JPS52118459A (en) 22furanone derivative and preparation thereof